Russia’s Pharmsynthez Plans £10.5 Million ($16.1 Million) IPO

Pharma Times -- Russia’s Pharmsynthez has unveiled plans to float on the Moscow Interbank Currency Exchange (MICEX) to help fund a new facility and international expansion.

MORE ON THIS TOPIC